Società Freeline Therapeutics Holdings plc
Azioni
FRLN
US35655L2060
Biotecnologia
Attività
Numero di dipendenti: 152
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Markus Hörer
FOU | Founder | - | 01/01/15 |
Michael Parini
CEO | Chief Executive Officer | 49 | 15/03/21 |
Paul Schneider
DFI | Director of Finance/CFO | 54 | 16/05/22 |
Chief Tech/Sci/R&D Officer | 57 | 01/03/22 | |
Pamela Foulds
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/11/21 |
James Bircher
COO | Chief Operating Officer | 56 | 01/07/21 |
Naomi Aoki
IRC | Investor Relations Contact | - | - |
Chip McCorkle
LAW | General Counsel | - | - |
Nicole Jones
HRO | Human Resources Officer | 54 | 11/07/22 |
Amy J. Spandau
PRN | Corporate Officer/Principal | - | 01/02/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chris Hollowood
CHM | Chairman | 50 | 01/12/15 |
Michael Parini
CEO | Chief Executive Officer | 49 | 15/03/21 |
Paul Schneider
DFI | Director of Finance/CFO | 54 | 16/05/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 65 369 417 | 64 715 513 ( 99,00 %) | 0 | 99,00 % |
Coordinate società
Freeline Therapeutics Holdings Plc
Sycamore House Gunnels Wood Road
SG1 2BP, Stevenage
+44 14 3890 6870
http://www.freeline.life![Indirizzo Freeline Therapeutics Holdings plc(FRLN)](https://cdn.zonebourse.com/static/address/110594703.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+20,12% | 126 Mrd | |
+25,25% | 119 Mrd | |
+25,56% | 27,95 Mrd | |
-19,51% | 20,5 Mrd | |
-14,36% | 17,12 Mrd | |
-15,63% | 16,1 Mrd | |
-46,67% | 14,97 Mrd | |
+11,89% | 14,84 Mrd | |
+57,74% | 14,38 Mrd |